Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

194,268 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effectiveness of S-1-Based Chemoradiotherapy in Patients 70 Years and Older With Esophageal Squamous Cell Carcinoma: A Randomized Clinical Trial.
Wang X, Han W, Zhang W, Wang X, Ge X, Lin Y, Zhou H, Hu M, Wang W, Liu K, Lu J, Qie S, Zhang J, Deng W, Wang L, Han C, Li M, Zhang K, Li L, Wang Q, Shi H, Yu Z, Zhao Y, Sun X, Shi Y, Pang Q, Zhou Z, Liang J, Chen D, Feng Q, Bi N, Zhang T, Deng L, Wang W, Liu W, Wang J, Zhai Y, Wang J, Chen W, Chen J, Xiao Z; Jing-Jin-Ji Esophageal and Esophagogastric Cancer Radiotherapy Oncology Group (3JECROG). Wang X, et al. Among authors: wang w, wang l, wang j, wang q. JAMA Netw Open. 2023 May 1;6(5):e2312625. doi: 10.1001/jamanetworkopen.2023.12625. JAMA Netw Open. 2023. PMID: 37195667 Free PMC article. Clinical Trial.
Intensity modulated radiotherapy might be effective for locally advanced esophageal carcinosarcoma: A single center's experience and review of literature.
Yang S, Wang W, Bi N, Zhou Z, Feng Q, Xiao Z, Chen D, Liang J, Lu J, Wang J, Wang X, Wang J, Yang Y, Lu N, Zhang H, Wang L. Yang S, et al. Among authors: wang x, wang w, wang l, wang j. Medicine (Baltimore). 2022 Oct 21;101(42):e31215. doi: 10.1097/MD.0000000000031215. Medicine (Baltimore). 2022. PMID: 36281080 Free PMC article. Review.
Progression-free survival as surrogate endpoint of overall survival in esophageal squamous cell carcinoma: a real-world data and literature-based analysis.
Han W, Wang L, Li C, Chen J, Zhang W, Wang X, Pang Q, Zhao Y, Sun X, Zhang K, Li G, Li L, Qiao X, Liu M, Wang Y, Deng L, Wang W, Bi N, Zhang T, Deng W, Ni W, Chang X, Zhou Z, Liang J, Feng Q, Wang L, Chen D, Lv J, Zhu S, Han C, Xiao Z. Han W, et al. Among authors: wang x, wang w, wang l, wang y. Ther Adv Med Oncol. 2022 Oct 28;14:17588359221131526. doi: 10.1177/17588359221131526. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 36324733 Free PMC article.
Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma.
Han W, Deng W, Wang Q, Ni W, Li C, Zhou Z, Liang J, Chen D, Feng Q, Bi N, Zhang T, Wang X, Deng L, Wang W, Liu W, Wang J, Xue Q, Mao Y, Liu X, Fang D, Li J, Wang D, Zhao J, Xiao Z. Han W, et al. Among authors: wang x, wang w, wang j, wang d, wang q. Front Oncol. 2022 Nov 10;12:998238. doi: 10.3389/fonc.2022.998238. eCollection 2022. Front Oncol. 2022. PMID: 36439431 Free PMC article.
Induction Immune Checkpoint Inhibitors and Chemotherapy Before Definitive Chemoradiation Therapy for Patients With Bulky Unresectable Stage III Non-Small Cell Lung Cancer.
Wang Y, Zhang T, Wang J, Zhou Z, Liu W, Xiao Z, Deng L, Feng Q, Wang X, Lv J, Ma X, Xue Q, Wang J, Wang Z, Bi N. Wang Y, et al. Among authors: wang x, wang j, wang z. Int J Radiat Oncol Biol Phys. 2023 Jul 1;116(3):590-600. doi: 10.1016/j.ijrobp.2022.12.042. Epub 2023 Jan 7. Int J Radiat Oncol Biol Phys. 2023. PMID: 36623605
Efficacy and Safety of Concurrent Chemoradiotherapy Combined with Nimotuzumab in Elderly Patients with Esophageal Squamous Cell Carcinoma: A Prospective Real-world Pragmatic Study.
Yu N, Cheng G, Li J, Liang J, Zhang T, Deng L, Liu W, Wang J, Zhai Y, Wang W, Xiao Z, Zhou Z, Chen D, Feng Q, Bi N, Wang X. Yu N, et al. Among authors: wang x, wang w, wang j. Curr Cancer Drug Targets. 2023;23(8):653-662. doi: 10.2174/1568009623666230315145937. Curr Cancer Drug Targets. 2023. PMID: 36924100 Clinical Trial.
Decreased lymphoma-related deaths and improved long-term relative survival with radiotherapy for early-stage diffuse large B-cell lymphoma in the rituximab era.
Wang X, Liu X, Zhong QZ, Wu T, Wu YP, Yang Y, Chen B, Jing H, Tang Y, Jin J, Liu YP, Song YW, Fang H, Lu NN, Li N, Zhai YR, Zhang WW, Wang SL, Chen F, Qi SN, Li YX. Wang X, et al. Among authors: wang sl. Radiother Oncol. 2023 Nov;188:109902. doi: 10.1016/j.radonc.2023.109902. Epub 2023 Sep 9. Radiother Oncol. 2023. PMID: 37678622
Corrigendum: Superiority of integrated cervicothoracic immobilization in the setup of lung cancer patients treated with supraclavicular station irradiation.
Wan B, Luo S, Feng X, Qin W, Sun H, Hou L, Zhang K, Zhou SWZ, Xiao Z, Chen D, Feng Q, Wang X, Huan F, Bi N, Wang J. Wan B, et al. Among authors: wang x, wang j. Front Oncol. 2023 Aug 24;13:1276782. doi: 10.3389/fonc.2023.1276782. eCollection 2023. Front Oncol. 2023. PMID: 37692842 Free PMC article.
194,268 results
You have reached the last available page of results. Please see the User Guide for more information.